Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Keiichi, Yonemori"'
Indications for and Safety of Surgery for Gastrointestinal Cancer with Concomitant Hepatic Cirrhosis
Autor:
Keiichi YONEMORI, Masahiko SAKODA, Yuki HIRASE, Akihiko SAKAMOTO, Takao OTSUKA, Shigeho MAENOHARA
Publikováno v:
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 83:1882-1889
Publikováno v:
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 82:673-678
Autor:
Yusei Haraguchi, Noriko Yamamoto, Shinichi Maeda, Shoji Natsugoe, Kensuke Nuruki, Keiichi Yonemori
Publikováno v:
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 80:2201-2206
Autor:
KEIICHI YONEMORI1, HIROSHI KURAHARA1 h-krhr@m3.kufm.kagoshima-u.ac.jp, KOSEI MAEMURA1, YUKO MATAKI1, MASAHIKO SAKODA1, SATOSHI IINO1, SHINICHI UENO2, HIROYUKI SHINCHI3, SHOJI NATSUGOE1
Publikováno v:
Oncology Letters. Aug2017, Vol. 14 Issue 2, p1697-1702. 6p.
Autor:
Yuko Mataki, Atsushi Okato, Yusaku Osako, Hiroshi Kurahara, Takayuki Arai, Tetsuya Idichi, Shoji Natsugoe, Keiichi Koshizuka, Yuko Kijima, Yoshiaki Kita, Takaaki Arigami, Kosei Maemura, Keiichi Yonemori, Naohiko Seki
Publikováno v:
Oncotarget. 8:70097-70115
// Keiichi Yonemori 1 , Naohiko Seki 2 , Tetsuya Idichi 1 , Hiroshi Kurahara 1 , Yusaku Osako 1 , Keiichi Koshizuka 2 , Takayuki Arai 2 , Atsushi Okato 2 , Yoshiaki Kita 1 , Takaaki Arigami 1 , Yuko Mataki 1 , Yuko Kijima 1 , Kosei Maemura 1 and Shoj
Autor:
Yuko Kijima, Takayuki Arai, Yoshiaki Kita, Yuko Mataki, Shoji Natsugoe, Takaaki Arigami, Hiroshi Kurahara, Atsushi Okato, Yusaku Osako, Tetsuya Idichi, Keiichi Yonemori, Naohiko Seki, Kosei Maemura
Publikováno v:
Oncotarget. 8:53180-53193
// Tetsuya Idichi 1 , Naohiko Seki 2 , Hiroshi Kurahara 1 , Keiichi Yonemori 1 , Yusaku Osako 1 , Takayuki Arai 2 , Atsushi Okato 2 , Yoshiaki Kita 1 , Takaaki Arigami 1 , Yuko Mataki 1 , Yuko Kijima 1 , Kosei Maemura 1 and Shoji Natsugoe 1 1 Departm
Publikováno v:
Journal of Human Genetics. 62:33-40
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal malignancies. Patients with PDAC are often asymptomatic, and many have lymph node and distant metastases as well as vessel invasion upon diagnosis. Surgery and current chemotherapy hav
Autor:
Keiichi, Yonemori, Naohiko, Seki, Tetsuya, Idichi, Hiroshi, Kurahara, Yusaku, Osako, Keiichi, Koshizuka, Takayuki, Arai, Atsushi, Okato, Yoshiaki, Kita, Takaaki, Arigami, Yuko, Mataki, Yuko, Kijima, Kosei, Maemura, Shoji, Natsugoe
Publikováno v:
Oncotarget
We analysed the RNA sequence-based microRNA (miRNA) signature of pancreatic ductal adenocarcinoma (PDAC). Aberrantly expressed miRNAs were successfully identified in this signature. Using the PDAC signature, we focused on 4 clustered miRNAs, miR-216a
Autor:
Tetsuya, Idichi, Naohiko, Seki, Hiroshi, Kurahara, Keiichi, Yonemori, Yusaku, Osako, Takayuki, Arai, Atsushi, Okato, Yoshiaki, Kita, Takaaki, Arigami, Yuko, Mataki, Yuko, Kijima, Kosei, Maemura, Shoji, Natsugoe
Publikováno v:
Oncotarget
Analysis of our microRNA (miRNA) expression signature of pancreatic ductal adenocarcinoma (PDAC) revealed that microRNA-217 (miR-217) was significantly reduced in cancer tissues. The aim of this study was to investigate the antitumor roles of miR-217
Autor:
Ken Sasaki, Keiichi Koshizuka, Akira Kurozumi, Yasuto Uchikado, Itaru Omoto, Yoshiaki Kita, Shoji Natsugoe, Yusaku Osako, Keiichi Yonemori, Naohiko Seki, Hiroshi Kurahara, Kosei Maemura
Publikováno v:
International Journal of Oncology
Esophageal squamous cell carcinoma (ESCC) is one of the most aggressive malignancies. Recently developed molecular targeted therapies are not available for patients with ESCC. After curative surgical resection, patients frequently suffer distant meta